Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Delisting Announcement 2026

Apr 8, 2026

5229_dlst_2026-04-08_c4c396dd-1854-400b-b851-c43299b8e9e0.zip

Delisting Announcement

Open in viewer

Opens in your device viewer

EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the Guarantor of the stated securities from listing and registration on the Exchange at the opening of business on April 20, 2026, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d2-2(a)(2) That the entire class of this security was redeemed or paid at maturity or retirement on April 08, 2026. The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on April 08, 2026.